Related Experiment Video
Updated: Nov 30, 2025
An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation
Published on: October 31, 2025
Emerging Therapies to Prevent Post-ERCP Pancreatitis
Nikhil R Thiruvengadam1,2, Michael L Kochman3,4
1Division of Gastroenterology and Hepatology, University of California San Francisco, 513 Parnassus Avenue, S-357, Box 0538, San Francisco, CA, 94143-0538, USA. Nikhil.Thiruvengadam@ucsf.edu.
Rectal indomethacin and aggressive hydration effectively prevent post-ERCP pancreatitis in most patients. Pancreatic-duct stents benefit high-risk individuals, while tacrolimus shows promise for future prevention strategies.
Area of Science:
- Gastroenterology
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Pancreatitis Prevention
Background:
- Post-ERCP pancreatitis (PEP) is a significant complication.
- Effective prevention strategies are crucial for patient safety.
- Novel therapies are continuously being investigated.
Purpose of the Study:
- To review emerging therapies for preventing post-ERCP pancreatitis.
- To evaluate the efficacy of novel agents and protocols.
Main Methods:
- Systematic review of recent literature.
- Analysis of clinical trial data on various preventative measures.
Main Results:
- Rectal indomethacin reduces PEP risk in low- to average-risk patients.
- Aggressive lactated Ringer's hydration (8-h protocol) benefits average-risk patients.
- Pancreatic-duct stents are effective in high-risk patients.
- Sublingual nitrates may enhance NSAID efficacy.
- Tacrolimus shows potential but requires further study.
Conclusions:
- Rectal indomethacin is recommended for routine PEP prevention.
- Aggressive hydration and nitrates show promise for enhanced prevention.
- Pancreatic-duct stents are vital for high-risk ERCP procedures.
More Related Videos
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:26Endoscopic Procedures V: ERCP
Patient...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:27Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...